Researchers Explore Additional Coding Potential Hidden in the Human Genome

Sequencing the human genome was just the first step. The next challenge is of the kind that makes history: to decode the genome, and understand how the information needed to construct a human being can be packaged into a single molecule. And there are a lot more than loose ends in the way of a solution. A group of bioinformatics experts at the Spanish National Cancer Research Centre (CNIO) in Madrid have published findings which point to still unexplored coding potential within the genome.

The substance responsible is chimeric RNA, formed not from one gene but from fragments of several. "There is growing evidence, some of it very recent, that genome coding is more complicated than we thought, and that some RNAs may combine information from two distinct genes," explains Alfonso Valencia, head of the CNIO's Structural Biology and Biocomputing Program. "We have called them chimeric RNAs after the mythological beings made from the parts of two different animals," he relates.

The research has been carried out in collaboration with scientists from the Centro de Regulación Genómica (CRG) in Barcelona. "We noted the prevalence of this phenomenon back in 2006, and are now working to establish its biological importance," remarks Roderic Guigó, coordinator of the CRG's Bioinformatics and Genomics program.

DNA contains the genes, which are translated into proteins. RNA, meantime, serves as an intermediary molecule performing what is an indispensable step in the process: before a gene can be translated into a protein, the right RNA has to be built. The classical vision of how information is stored in the genome holds that the correspondence is one-to-one, that is: one gene, one RNA, one protein.

A paradigm shift needed
And that was what scientists expected to find when they sequenced the genome at the start of the last decade. But it was quickly apparent that there was a problem: the human genome contains some 20,000 genes, while the variety of proteins in the human body is considerably greater. Something was wrong.

We now know that a single gene can produce several proteins; just as a words like "bat", "foot" or "count" can have different meanings despite being written the same way. But it remains to be seen whether this is a common phenomenon - whether all genes can code for multiple proteins – or a rarity. In fact, here too Valencia's group has made advances, demonstrating in a paper published last April in Molecular Evolution Biology that the translation of a single gene into several proteins occurs, but is fairly uncommon.

Chimeric RNA is also partly responsible for there being more distinct proteins than there are genes. As if the system reading and translating the genes could find three or more meanings from any two. So, for example, "love" and "cast" would be direct translations, but we would also get "ve-st"; "ca-ve"; "lo-st"...

The existence of chimeric RNA was already an established fact, and it was also known that some chimeric RNAs are translated into proteins, while others remain in the RNA phase, as happens with normal, non-chimeric RNA. But chimeric proteins were generally believed to be a rarity confined to pathological processes like the development of cancer.

The CNIO's bioinformatics team trawled through gene, RNA and protein databases and conducted new experiments before finally discovering that chimeric RNA is present in far greater quantities than was first thought. They have also detected cases of translation to proteins as part of an apparently normal process in healthy as well as cancerous tissue.

Their results have been written up in a series of papers, the latest of which has just appeared in Genome Research (Frenkel-Morgenstern et al, 2012, PMID: 22588898) signed as first author by Milana Frenkel-Morgenstern, from the CNIO Structural Computational Biology Group that Valencia leads. The interest has been such that another journal, Nature Reviews Genetics, dedicated a commentary to the article (Post transcriptional regulation: Chimeric protein production, NRG, June 7, 2012, 10.1038/nrg3268).

Specifically, the CNIO researchers have identified 175 chimeric RNA transcripts in 16 human tissues, and 12 new chimeric proteins. This finding poses numerous questions: How important is this process out of all the information in the genome? Does it finally explain the mismatch between the number of genes and proteins? What is the total number of chimeric proteins? Is there some function that characterises them? Why do they exist?

"We have opened up a line of inquiry which we hope other groups will now pursue," remarks Valencia. "In my opinion, the key thing about this research is that it shows we still have a lot to learn before we fully understand what is written in the genome."

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...